COVID-19 vaccine trial in US nonetheless on maintain, says AstraZeneca Plc


September 20

AstraZeneca Plc mentioned on Saturday that its COVID-19 vaccine trial within the United States remains to be on maintain.

AstraZeneca on Saturday printed a doc https://bit.ly/2FNcqu7 describing particulars of how the COVID-19 vaccine trial was being carried out, which was first reported by the New York Times. https://nyti.ms/3mzCmdb (Reuters)



Be the first to comment on "COVID-19 vaccine trial in US nonetheless on maintain, says AstraZeneca Plc"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: